In April 2026, Farmak International* opened a representative office in Mexico City, the capital of Mexico and one of the largest pharmaceutical markets in Latin America. The new office strengthens the company’s regional presence and supports the continued expansion of its international business operations.
The representative office is located in Santa Fe, one of Mexico City’s leading business districts. Farmak International’s local team will focus on strengthening partnerships, responding effectively to market needs, and expanding the company’s product portfolio in Mexico and across Latin America.
Farmak medicinal products have been available in Mexico since 2020. The company’s portfolio in the country includes medicines for ophthalmology, anesthesiology, hormone therapy, antithrombotic treatment, as well as products supporting metabolic health.
On June 3, 2026, Farmak International held an official opening ceremony attended by the company’s leadership team, local employees, and business partners.
The event featured a symbolic ribbon-cutting ceremony led by Viktor Kostiuk, CEO and Chairman of the Board of Directors of Farmak International; Roberto Asensio, Business Development Director; Marcel Puyol, HR and Corporate Culture Director; Xavier Luzuriaga, Head of Farmak International’s Business in Mexico; and Taras Yakovenko, Global Portfolio Development Director.
Farmak Group is a global pharmaceutical business founded in Ukraine in 1925. The Group operates manufacturing facilities in Ukraine and Spain and maintains subsidiaries and representative offices in Poland, the Czech Republic, Slovakia, the United Kingdom, the UAE, Vietnam, Switzerland, Mexico, Kazakhstan, Uzbekistan, Kyrgyzstan, and Moldova. Farmak products are exported to more than 60 countries worldwide, including 17 EU member states.
*Farmak International is responsible for the global operations of the Farmak Group, including the management of international assets and the development of business activities across foreign markets.
